JP2022542305A5 - - Google Patents
Info
- Publication number
- JP2022542305A5 JP2022542305A5 JP2022506062A JP2022506062A JP2022542305A5 JP 2022542305 A5 JP2022542305 A5 JP 2022542305A5 JP 2022506062 A JP2022506062 A JP 2022506062A JP 2022506062 A JP2022506062 A JP 2022506062A JP 2022542305 A5 JP2022542305 A5 JP 2022542305A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- dopa
- kinase inhibitor
- administration
- fasudil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025141689A JP2025169440A (ja) | 2019-07-31 | 2025-08-27 | Ｌ－ドパ誘発性ジスキネジアの予防的及び／又は治療的処置において使用するための医薬組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201930713A ES2804076B2 (es) | 2019-07-31 | 2019-07-31 | Composicion farmaceutica para su uso en el tratamiento profilactico y/o terapeutico de discinesias inducidas por l-dopa |
| ESP201930713 | 2019-07-31 | ||
| PCT/ES2020/070482 WO2021019116A1 (es) | 2019-07-31 | 2020-07-24 | Composición farmacéutica para su uso en el tratamiento profiláctico y/o terapéutico de discinesias inducidas por l-dopa |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025141689A Division JP2025169440A (ja) | 2019-07-31 | 2025-08-27 | Ｌ－ドパ誘発性ジスキネジアの予防的及び／又は治療的処置において使用するための医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022542305A JP2022542305A (ja) | 2022-09-30 |
| JP2022542305A5 true JP2022542305A5 (https=) | 2024-09-11 |
| JP7780420B2 JP7780420B2 (ja) | 2025-12-04 |
Family
ID=74229008
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022506062A Active JP7780420B2 (ja) | 2019-07-31 | 2020-07-24 | Ｌ－ドパ誘発性ジスキネジアの予防的及び／又は治療的処置において使用するための医薬組成物 |
| JP2025141689A Pending JP2025169440A (ja) | 2019-07-31 | 2025-08-27 | Ｌ－ドパ誘発性ジスキネジアの予防的及び／又は治療的処置において使用するための医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025141689A Pending JP2025169440A (ja) | 2019-07-31 | 2025-08-27 | Ｌ－ドパ誘発性ジスキネジアの予防的及び／又は治療的処置において使用するための医薬組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11337985B2 (https=) |
| EP (1) | EP4005574B1 (https=) |
| JP (2) | JP7780420B2 (https=) |
| KR (1) | KR20220050905A (https=) |
| CN (1) | CN114401725A (https=) |
| CA (1) | CA3145360A1 (https=) |
| ES (2) | ES2804076B2 (https=) |
| WO (1) | WO2021019116A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2804076B2 (es) * | 2019-07-31 | 2021-07-12 | Univ Santiago Compostela | Composicion farmaceutica para su uso en el tratamiento profilactico y/o terapeutico de discinesias inducidas por l-dopa |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2804076B2 (es) * | 2019-07-31 | 2021-07-12 | Univ Santiago Compostela | Composicion farmaceutica para su uso en el tratamiento profilactico y/o terapeutico de discinesias inducidas por l-dopa |
-
2019
- 2019-07-31 ES ES201930713A patent/ES2804076B2/es active Active
-
2020
- 2020-07-24 EP EP20847817.2A patent/EP4005574B1/en active Active
- 2020-07-24 KR KR1020227006569A patent/KR20220050905A/ko active Pending
- 2020-07-24 ES ES20847817T patent/ES2987334T3/es active Active
- 2020-07-24 CA CA3145360A patent/CA3145360A1/en active Pending
- 2020-07-24 WO PCT/ES2020/070482 patent/WO2021019116A1/es not_active Ceased
- 2020-07-24 JP JP2022506062A patent/JP7780420B2/ja active Active
- 2020-07-24 CN CN202080053643.6A patent/CN114401725A/zh active Pending
-
2021
- 2021-08-19 US US17/406,689 patent/US11337985B2/en active Active
-
2022
- 2022-03-22 US US17/701,391 patent/US12465613B2/en active Active
-
2025
- 2025-08-27 JP JP2025141689A patent/JP2025169440A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023041862A5 (https=) | ||
| ES2222522T3 (es) | Tratamiento de la migraña utilizando metoclopramida y un nsaid. | |
| JP2014515373A5 (https=) | ||
| JP2019516733A5 (https=) | ||
| HRP20150644T1 (hr) | Metoda za lijeäśenje atrijalne fibrilacije | |
| HRP20130052T1 (hr) | Lijeäśenje respiratorne bolesti | |
| ATE350040T1 (de) | Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin | |
| IL273169B1 (en) | New combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (pf-ild) | |
| JP2022163049A5 (https=) | ||
| JP2019536812A5 (https=) | ||
| JP2015510916A5 (https=) | ||
| JP2019529570A5 (https=) | ||
| JP2020529995A5 (https=) | ||
| EP4599894A3 (en) | Methods of treating chronic spontaneous urticaria using a bruton s tyrosine kinase inhibitor | |
| JP2016507500A5 (https=) | ||
| CN101939001B (zh) | 用于治疗卵巢癌的含有紫杉醇的组合 | |
| JP2009517411A5 (https=) | ||
| RU2008134143A (ru) | Фармацевтическая композиция цитиколина, холина альфосцерата и l-карнитина (или ацетил-l-карнитина) для лечения и профилактики заболеваний центральной нервной системы и способ лечения | |
| JP2022542305A5 (https=) | ||
| JP2016505050A5 (https=) | ||
| CN113876775B (zh) | 一种青藤碱或其药物可接受的盐作为治疗动脉性肺动脉高压药物的用途 | |
| JP2022517902A5 (https=) | ||
| JP5386478B2 (ja) | パーキンソン病に伴う運動不全の治療のための４−シクロプロピルメトキシ−ｎ−（３，５−ジクロロ−１−オキシドピリジン−４−イル）−５−（メトキシ）ピリジン−２−カルボキサミドの使用 | |
| US20100022608A1 (en) | Non-steroidal anti-inflammatory drugs for cough | |
| JP2022512158A5 (https=) |